Bristol Myers Squibb

This summary outlines the business activities and related topics covered in the Item 1. Business section and adjacent filings.

Topics covered in Item 1. Business

• Acquisitions, divestitures, licensing and other arrangements
• Products, intellectual property and product exclusivity
• Research and development
• Alliances and strategic collaborations
• Marketing, distribution and customers
• Competition
• Pricing, price constraints and market access
• Government regulation
• Sources and availability of raw materials
• Manufacturing and quality assurance
• Environmental regulation
• Human capital management and resources
• Foreign operations
• Reference to the Bristol Myers Squibb website

Related sections commonly included in the filing

• Item 1A. Risk Factors
• Item 1B. Unresolved Staff Comments
• Item 1C. Cybersecurity
• Item 2. Properties
• Item 3. Legal Proceedings
• Item 4. Mine Safety Disclosures
• Part IA. Information about our Executive Officers

Overall focus

• Ongoing corporate activity: acquisitions, divestitures, licensing and partnerships that shape the company’s portfolio and strategy.
• Product lifecycle management: development, protection and commercialization of products, with attention to intellectual property and exclusivity.
• Research and development to advance the pipeline and support approved products.
• Commercial operations: marketing, distribution and customer engagement across competitive markets.
• Market access and pricing strategies within regulatory frameworks.
• Supply chain coordination: sourcing raw materials, manufacturing and maintaining quality assurance.
• Compliance with environmental and other regulatory requirements.
• Management of human capital and global operations.
• Corporate governance and disclosure of risks, cybersecurity, legal matters and other topics typical of a 10-K filing.